MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • Singapore-MIT Alliance (SMA)
  • Molecular Engineering of Biological and Chemical Systems (MEBCS)
  • View Item
  • DSpace@MIT Home
  • Singapore-MIT Alliance (SMA)
  • Molecular Engineering of Biological and Chemical Systems (MEBCS)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Prion Protein is Expressed on Long-term Repopulating Hematopoietic Stem Cells and is Necessary for their Self-renewal

Author(s)
Lodish, Harvey F.; Zhang, Cheng Cheng; Steele, Andrew D.; Lindquist, Susan L.
Thumbnail
DownloadMEBCS017.pdf (11.57Kb)
Metadata
Show full item record
Abstract
We show that the prion protein (PrP) is expressed on the surface of bone marrow cell populations enriched in long-term repopulating hematopoietic stem cells. Affinity purification of the PrP-positive and PrP-negative fractions from these populations, followed by competitive reconstitution assays, show that all long-term repopulating hematopoietic stem cells express PrP. Hematopoietic stem cells from PrP null bone marrow exhibit impaired self-renewal in serial competitive transplantation experiments, and premature exhaustion when exposed to cell cycle-specific myelotoxic injury. Therefore, PrP is a novel marker for hematopoietic stem cells and regulates their self-renewal.
Date issued
2005-01
URI
http://hdl.handle.net/1721.1/7488
Series/Report no.
Molecular Engineering of Biological and Chemical Systems (MEBCS);
Keywords
Prion Proteins, PrP, hematopoietic stem cells, bone marrow cells

Collections
  • Molecular Engineering of Biological and Chemical Systems (MEBCS)

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.